Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008;14(27):4300–4308. doi:10.3748/wjg.14.4300
   PubMed Web of Science ®Google Scholar
• Parikh S, Hyman D. Hepatocellular cancer: a guide for the internist. Am J Med. 2007;120(3):194–202. doi:10.1016/j.amjmed.2006.11.020
   PubMed Web of Science ®Google Scholar
• Singal AG, El-Serag HB. Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin Gastroenterol Hepatol. 2015;13(12):2140–2151. doi:10.1016/j.cgh.2015.08.014
   PubMed Web of Science ®Google Scholar
• Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362(9399):1907–1917. doi:10.1016/s0140-6736(03)14964-1
   PubMed Web of Science ®Google Scholar
• Lopez PM, Villanueva A, Llovet JM. Systematic review: evidence-based management of hepatocellular carcinoma – an updated analysis of randomized controlled trials. Aliment Pharmacol Ther. 2006;23(11):1535–1547. doi:10.1111/j.1365-2036.2006.02932.x
   PubMed Web of Science ®Google Scholar
• Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63(5):844–855. doi:10.1136/gutjnl-2013-306627
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(Suppl):245–254. doi:10.1038/ng1089
   PubMed Web of Science ®Google Scholar
• Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 2006;31(2):89–97. doi:10.1016/j.tibs.2005.12.008
   PubMed Web of Science ®Google Scholar
• Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6(9):674–687. doi:10.1038/nrc1934
   PubMed Web of Science ®Google Scholar
• Sceusi EL, Loose DS, Wray CJ. Clinical implications of DNA methylation in hepatocellular carcinoma. HPB. 2011;13(6):369–376. doi:10.1111/j.1477-2574.2011.00303.x
   PubMed Web of Science ®Google Scholar
• Song MA, Tiirikainen M, Kwee S, Okimoto G, Yu H, Wong LL. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. PLoS One. 2013;8(2):e55761. doi:10.1371/journal.pone.0055761
   PubMed Web of Science ®Google Scholar
• Goodwin S, McPherson JD, McCombie WR. Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet. 2016;17(6):333–351. doi:10.1038/nrg.2016.49
   PubMed Web of Science ®Google Scholar
• Huang W, Skanderup AJ, Lee CG. Advances in genomic hepatocellular carcinoma research. Gigascience. 2018;7(11). doi:10.1093/gigascience/giy135
   Web of Science ®Google Scholar
• Nakagawa H, Shibata T. Comprehensive genome sequencing of the liver cancer genome. Cancer Lett. 2013;340(2):234–240. doi:10.1016/j.canlet.2012.10.035
   PubMed Web of Science ®Google Scholar
• Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207–210. doi:10.1093/nar/30.1.207
   PubMed Web of Science ®Google Scholar
• Tischoff I, Tannapfe A. DNA methylation in hepatocellular carcinoma. World J Gastroenterol. 2008;14(11):1741–1748. doi:10.3748/wjg.14.1741
   PubMed Web of Science ®Google Scholar
• Gailhouste L, Liew LC, Yasukawa K, et al. Differentiation therapy by epigenetic reconditioning exerts antitumor effects on liver cancer cells. Mol Ther. 2018;26(7):1840–1854. doi:10.1016/j.ymthe.2018.04.018
   PubMed Web of Science ®Google Scholar
• Raggi C, Factor VM, Seo D, et al. Epigenetic reprogramming modulates malignant properties of human liver cancer. Hepatology. 2014;59(6):2251–2262. doi:10.1002/hep.27026
   PubMed Web of Science ®Google Scholar
• Engedal N, Torgersen ML, Guldvik IJ, et al. Modulation of intracellular calcium homeostasis blocks autophagosome formation. Autophagy. 2013;9(10):1475–1490. doi:10.4161/auto.25900
   PubMed Web of Science ®Google Scholar
• White E, Mehnert JM, Chan CS. Autophagy, metabolism, and cancer. Clin Cancer Res. 2015;21(22):5037–5046. doi:10.1158/1078-0432.CCR-15-0490
   PubMed Web of Science ®Google Scholar
• Vesely DL, Elchelbrum EJ, Sun Y, et al. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones. In Vivo. 2007;21:445–452.
   PubMed Web of Science ®Google Scholar
• Hara M, Takeba Y, Iiri T, et al. Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl-xL pathway. Cancer Sci. 2019;110(1):235–244. doi:10.1111/cas.13861
   PubMed Web of Science ®Google Scholar
• Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2(8):563–572. doi:10.1038/nrc865
   PubMed Web of Science ®Google Scholar
• Yilmaz M, Christofori G, Lehembre F. Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med. 2007;13(12):535–541. doi:10.1016/j.molmed.2007.10.004
   PubMed Web of Science ®Google Scholar
• Zhang C, Peng L, Zhang Y, et al. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. Med Oncol. 2017;34(6):101. doi:10.1007/s12032-017-0963-9
   PubMed Web of Science ®Google Scholar
• Evdokimov K, Biswas S, Schledzewski K, et al. Leda-1/Pianp is targeted to the basolateral plasma membrane by a distinct intracellular juxtamembrane region and modulates barrier properties and E-Cadherin processing. Biochem Biophys Res Commun. 2016;475(4):342–349. doi:10.1016/j.bbrc.2016.05.092
   PubMed Web of Science ®Google Scholar
• Werner H, Maor S. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action. Trends Endocrinol Metab. 2006;17(6):236–242. doi:10.1016/j.tem.2006.06.007
   PubMed Web of Science ®Google Scholar
• Adamek A, Kasprzak A. Insulin-Like Growth Factor (IGF) system in liver diseases. Int J Mol Sci. 2018;19(5). doi:10.3390/ijms19051308
   Web of Science ®Google Scholar
• Hui F, Qin X, Zhang Q, et al. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo. Biomed Pharmacother. 2019;109:2365–2374. doi:10.1016/j.biopha.2018.11.124
   PubMed Web of Science ®Google Scholar
• Hou Y, Sun G, Jiang X, Zhu Z, Yang J. Nuclear forkhead box O3a accumulation contributing to the proliferative suppression in liver cancer cells by PI3K/Akt signaling pathway. J Cancer Res Ther. 2018;1998–4138. doi:10.4103/0973-1482.204891
   Web of Science ®Google Scholar
• Huang GM, Jiang QH, Cai C, Qu M, Shen W. SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway. Cancer Lett. 2015;358(2):180–190. doi:10.1016/j.canlet.2014.12.036
   PubMed Web of Science ®Google Scholar
• Liu Z, Gartenhaus RB, Tan M, Jiang F, Jiao X. Gene and pathway identification with Lp penalized Bayesian logistic regression. BMC Bioinform. 2008;9:412. doi:10.1186/1471-2105-9-412
   PubMed Web of Science ®Google Scholar
• Tao R, Li J, Xin J, et al. Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma. PLoS One. 2011;6(5):e19862. doi:10.1371/journal.pone.0019862
   PubMed Web of Science ®Google Scholar
• Fan Z, Duan J, Wang L, et al. PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/beta-catenin signaling. Cancer Lett. 2019;450:132–143. doi:10.1016/j.canlet.2019.02.040
   PubMed Web of Science ®Google Scholar
• Weisser M, Yeh RF, Duchateau-Nguyen G, et al. PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia. Blood. 2014;124(3):420–425. doi:10.1182/blood-2013-12-538975
   PubMed Web of Science ®Google Scholar
• Franchini M, Lippi G. The role of von Willebrand factor in hemorrhagic and thrombotic disorders. Crit Rev Clin Lab Sci. 2007;44(2):115–149. doi:10.1080/10408360600966753
   PubMed Web of Science ®Google Scholar
• Xiang Y, Hwa J. Regulation of VWF expression, and secretion in health and disease. Curr Opin Hematol. 2016;23(3):288–293. doi:10.1097/MOH.0000000000000230
   PubMed Web of Science ®Google Scholar
• Franchini M, Frattini F, Crestani S, Bonfanti C, Lippi G. von Willebrand factor and cancer: a renewed interest. Thromb Res. 2013;131(4):290–292. doi:10.1016/j.thromres.2013.01.015
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang X, Li S, et al. The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study. J Proteomics. 2014;106:99–112. doi:10.1016/j.jprot.2014.04.021
   PubMed Web of Science ®Google Scholar
• San Antonio JD, Zoeller JJ, Habursky K, et al. A key role for the integrin alpha2beta1 in experimental and developmental angiogenesis. Am J Pathol. 2009;175(3):1338–1347. doi:10.2353/ajpath.2009.090234
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ramirez NE, Yankeelov TE, et al. Alpha2beta1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner. Blood. 2008;111(4):1980–1988. doi:10.1182/blood-2007-06-094680
   PubMed Web of Science ®Google Scholar
• Lian XY, Zhang W, Wu DH, et al. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia. J Cell Physiol. 2018;233(12):9584–9593. doi:10.1002/jcp.26866
   PubMed Web of Science ®Google Scholar
• Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519–2531. doi:10.1016/s0140-6736(16)00576-6
   PubMed Web of Science ®Google Scholar
• Khristi V, Ratri A, Ghosh S, et al. Disruption of ESR1 alters the expression of genes regulating hepatic lipid and carbohydrate metabolism in male rats. Mol Cell Endocrinol. 2019;490:47–56. doi:10.1016/j.mce.2019.04.005
   PubMed Web of Science ®Google Scholar
• Deroo BJ, Buensuceso AV. Minireview: estrogen receptor-beta: mechanistic insights from recent studies. Mol Endocrinol. 2010;24(9):1703–1714. doi:10.1210/me.2009-0288
   PubMedGoogle Scholar
• Villa E, Moles A, Ferretti I, et al. Natural history of inoperable hepatocellular carcinoma: estrogen receptors’ status in the tumor is the strongest prognostic factor for survival. Hepatology. 2000;32(2):233–238. doi:10.1053/jhep.2000.9603
   PubMed Web of Science ®Google Scholar
• Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2008;317:121–124. doi:10.1126/science.1140485
   Web of Science ®Google Scholar
• Èller AM, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410(6824):50–56.
   PubMed Web of Science ®Google Scholar
• Samarendra H, Jones K, Petrinic T, et al. A meta-analysis of CXCL12 expression for cancer prognosis. Br J Cancer. 2017;117(1):124–135. doi:10.1038/bjc.2017.134
   PubMed Web of Science ®Google Scholar
• Xu H, Wei Y, Zhang Y, et al. Oestrogen attenuates tumour progression in hepatocellular carcinoma. J Pathol. 2012;228(2):216–229. doi:10.1002/path.4009
   PubMed Web of Science ®Google Scholar
• Beavo JA, Brunton LL. Cyclic nucleotide research — still expanding after half a century. Nat Rev Mol Cell Biol. 2002;3(9):710–718.
   PubMed Web of Science ®Google Scholar